53 Results

People

  1. Danishefsky
    Danishefsky
  2. Chou
    Chou
  3. Stachel
    Stachel
  4. Chappell
    Chappell
  5. Fornier
    Fornier
  6. Lee
    Lee
  7. Balog
    Balog
  8. Rivkin
    Rivkin
  9. Spriggs
    Spriggs
  10. Zhang
    Zhang

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (29)
  2. Sloan Kettering Institute Faculty (29)
  3. Department of Medicine (20)
  4. Solid Tumor Oncology Division (19)
  5. Breast Medicine Service (10)
  6. Survivorship Research (8)
  7. Sloan Kettering Institute Postdocs (7)
  8. Genitourinary Oncology Service (6)
  9. Biostatistics Service (4)
  10. Epidemiology and Biostatistics (4)
  1. "epothilones"
Formats
  1. Journal Article (52)
  2. Book Section (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (29)
  2. Sloan Kettering Institute Faculty (29)
  3. Department of Medicine (20)
  4. Solid Tumor Oncology Division (19)
  5. Breast Medicine Service (10)
  6. Survivorship Research (8)

More Groups

People
  1. Samuel Danishefsky (29)
  2. Ting-Chao Chou (20)
  3. Shawn Stachel (8)
  4. Chul Lee (7)
  5. Mark Chappell (7)
  6. Monica Fornier (7)

More People

Years
  1. 2013 (1)
  2. 2012 (3)
  3. 2010 (3)
  4. 2009 (4)
  5. 2008 (3)
  6. 2007 (8)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (7)
  2. Angewandte Chemie - International Edition (5)
  3. Journal of Clinical Oncology (5)
  4. Investigational New Drugs (4)
  5. Journal of Organic Chemistry (4)
  6. Journal of the American Chemical Society (4)

More Publications

Publishers
  1. American Chemical Society (10)
  2. Wiley Blackwell (9)
  3. National Academy of Sciences (7)
  4. American Society of Clinical Oncology (5)
  5. American Association for Cancer Research (4)
  6. Springer (4)

More Publishers

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Cestaro, J.; Obbens, E.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2007)

    Fulltext@MSK | Save
  • Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas
    Journal Article

    Aghajanian, C.; Burris, H. A. 3rd; Jones, S.; Spriggs, D. R.; Cohen, M. B.; Peck, R.; Sabbatini, P.; Hensley, M. L.; Greco, F. A.; Dupont, J.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: Second-line taxane-based therapy after first-line epothilone-B analog ixahepilone (BMS-247550) therapy
    Journal Article

    Rosenberg, J. E.; Galsky, M. D.; Rohs, N. C.; Weinberg, V. K.; Oh, W. K.; Kelly, W. K.; Small, E. J.
    Cancer (2006)

    Fulltext@MSK | Save
  • A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane
    Journal Article

    Ajani, J. A.; Safran, H.; Bokemeyer, C.; Shah, M. A.; Lenz, H. J.; Van Cutsem, E.; Burris, H. A. 3rd; Lebwohl, D.; Mullaney, B.
    Investigational New Drugs (2006)

    Fulltext@MSK | Save
  • Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo
    Journal Article

    Wu, K. D.; Cho, Y. S.; Katz, J.; Ponomarev, V.; Chen-Kiang, S.; Danishefsky, S. J.; Moore, M. A. S.
    Proceedings of the National Academy of Sciences of the United States of America (2005)

    Fulltext@MSK | Save
  • On the remarkable antitumor properties of fludelone: How we got there
    Journal Article

    Rivkin, A.; Chou, T. C.; Danishefsky, S. J.
    Angewandte Chemie - International Edition (2005)

    Fulltext@MSK | Save
  • Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer
    Journal Article

    Galsky, M. D.; Small, E. J.; Oh, W. K.; Chen, I.; Smith, D. C.; Colevas, A. D.; Martone, L.; Curley, T.; Delacruz, A.; Scher, H. I.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route
    Journal Article

    Chou, T. C.; Dong, H.; Zhang, X.; Tong, W. P.; Danishefsky, S. J.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • A comparison of signaling activities induced by taxol and desoxyepothilone B
    Journal Article

    Bergstralh, D. T.; Taxman, D. J.; Chou, T. C.; Danishefsky, S. J.; Ting, J. P. Y.
    Journal of Chemotherapy (2004)

    Fulltext@MSK | Save
  • Discovery of (E)-9,10-dehydroepothilones through chemical synthesis: On the emergence of 26-trifluoro-(E)-9,10-dehydro-12,13-desoxyepothilone B as a promising anticancer drug candidate
    Journal Article

    Rivkin, A.; Yoshimura, F.; Gabarda, A. E.; Cho, Y. S.; Chou, T. C.; Dong, H.; Danishefsky, S. J.
    Journal of the American Chemical Society (2004)

    Fulltext@MSK | Save